Flagship Harbor Advisors’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-405
Closed -$4.76K – 1652
2025
Q4
$4.76K Buy
+405
New +$4.37K ﹤0.01% 1665
2020
Q4
– Sell
-1,310
Closed -$48K – 1294
2020
Q3
$48K Buy
1,310
+425
+48% +$15.8K 0.01% 869
2020
Q2
$27K Buy
885
+50
+6% +$1.39K ﹤0.01% 1047
2020
Q1
$23K Buy
+835
New +$25K ﹤0.01% 983

Other funds holding NEO

Flagship Harbor Advisors's NEO Position: Q1 2026 in Review

Flagship Harbor Advisors sold out of NeoGenomics (NEO) in Q1 2026, closing a stake of 405 shares — an estimated $4.76K sold.

Flagship Harbor Advisors first reported a position in NEO in Q1 2020 and held it in 4 quarters. The position peaked at $48K in Q3 2020. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

  • Flagship Harbor Advisors reported no remaining NeoGenomics position as of Q1 2026 after selling out during the quarter.
  • Flagship Harbor Advisors sold 405 NeoGenomics shares in Q1 2026, an estimated $4.76K.
  • Flagship Harbor Advisors first reported a position in NeoGenomics in Q1 2020 and held it in 4 quarters.
  • Flagship Harbor Advisors's NeoGenomics position peaked at $48K in Q3 2020.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Flagship Harbor Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.